Summary
Allergic diseases represent a major health problem in Europe. They are increasing in prevalence, severity and costs. GA2LEN (Global Allergy and Asthma European Network), an FP6 Network of Excellence, was created in 2005 as a vehicle to ensure excellence in research bringing together research and clinical institutions to combat fragmentation in the European research area and to tackle allergy as a whole. GA2LEN benefited greatly from the voluntary efforts of researchers who are strongly committed to this model of pan-European collaboration. The network was organized in order to increase networking for scientific projects in allergy and asthma around Europe and to make GA2LEN the world leader in the field. Besides these activities, research has been jointly made and the first papers are being published. GA2LEN achievements in general can be grouped as those for a durable infrastructure built up during the project phase those which are project-related work based on these novel infrastructures, and the development and implementations of guidelines. The major achievements of GA2LEN are reported in this paper.
Zusammenfassung
Allergische Erkrankungen stellen eines der wesentlichen Gesundheitsprobleme in Europa dar. Häufigkeit, Schweregrad und Kosten dieser Erkrankungen weisen eine steigende Tendenz auf. 2005 wurde das GA2LEN Netzwerk (Global Allergy and Asthma European Network) gegründet, ein Exzellenz-Netzwerk des 6. EU Rahmenprogramms, das es sich zur Aufgabe gemacht hatte, Spitzenforschung sicherzustellen, indem es wissenschaftliche und klinische Einrichtungen vereinen sollte und dadurch die Aufsplitterung der europäischen Forschung überwinden könne. Allergien sollten als globales Problem in Angriff genommen werden. GA2LEN profitierte immens von den freiwilligen Anstrengungen der Wissenschaftler, die sich der Idee einer pan-europäischen Zusammenbarbeit verbunden fühlten. Ursprüngliches Ziel von GA2LEN war es gewesen, die Vernetzung wissenschaftlicher Projekte, die sich mit Allergien und Asthma in Europa beschäftigen, zu verstärken und das Netzwerk so an die weltweite Spitze der Allergie-Forschung zu setzen. Daneben wurden neue, gemeinsame Forschungsprojekte initiiert und gemeinsame Veröffentlichungen publiziert. Die Errungenschaften von GA2LEN lassen sich drei Untergruppen zuordnen: 1. den Aufbau einer tragfähigen Infrastruktur, 2. Projektbezogene Arbeit und 3. die Entwicklung und Implementierung von Leitlinien. In dieser Übersichtsarbeit werden die wichtigsten Errungenschaften des GA2LEN Netzwerks dargestellt.
Similar content being viewed by others
Referenzen
Bousquet J, Khaltaev N (2007) Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization. (ISBN 978 92 4 156346 8) 148 pages
Bousquet J, Van Cauwenberge P, Khaltaev N (2001) Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 [Suppl 5]: S147–334
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 63 [Suppl 86]: S8–160
Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A (2007) Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 120: 381–387
Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al (2008) Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 372 (9643): 1049–1057
Sullivan SD, Turk F (2008) An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 63: 670–684
Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al (2006) Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117: 158–162
Bousquet J, Demarteau N, Mullol J, van den Akker-van Marle ME, Van Ganse E, Bachert C (2005) Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 60: 788–794
Zuberbier T, Lötvall J (2008) Allergies have a socio-economic impact – a model calculation. European Academy of Allergology and Clinical Immunology, annual meeting. Barcelona June 2008. Allergy 63 [Suppl 88]: S621
2008–2013 Action plan for the global strategy for the prevention and control of non communicable diseases. Prevent and control cardiovascular diseases, cancers, chronic respiratory diseases, diabetes (2008). URL: www.who.int/nmh/Actionplan-PC-NCD-2008.pdf; accessed 13th Sep 2009
Bousquet J, Bieber T, Fokkens W, Kowalski ML, Humbert M, Niggemann B, et al (2008) Important questions in allergy: novel research areas. Allergy 63: 143–147
Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA, et al (2008) Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 63: 842–853
Demoly P, Pichler W, Pirmohamed M, Romano A (2008) Important questions in Allergy: 1 – drug allergy/hypersensitivity. Allergy 63: 616–619
Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, Scadding G, et al (2009) Important research questions in allergy and related diseases: 3-Chronic rhinonsinusitis – a GA2LEN study. Allergy 64: 520–533
Van Cauwenberge P, Watelet JB, Van Zele T, Bousquet J, Burney P, Zuberbier T (2005) Spreading excellence in allergy and asthma: the GA2LEN (Global Allergy and Asthma European Network) project. Allergy 60: 858–864
Warner JO (2006) Global Allergy and Asthma European Network (GA2LEN)-a focus for paediatric allergy research. Pediatr Allergy Immunol 17: 163
Frew AJ (2005) GA2LEN – The Global Allergy and Asthma European Network. Clin Exp Allergy 35: 122–125
Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, et al (2005) Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network. Allergy. 60: 1287–1300
Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Dahlen B, Dahlen S, et al (2007) Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy 62: 1111–1118
Turjanmaa K, Darsow U, Niggemann B, Rance F, Vanto T, Werfel T (2006) EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy 61: 1377–1384
Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rance F, Turjanmaa K, et al (2007) Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy 62: 723–728
Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, et al (2008) Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 63: 492–505
Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, et al (2008) Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 63: 387–403
Bonini S, Rasi G, Brusasco V, Carlsen KH, Crimi E, Popov T, et al (2007) Nonspecific provocation of target organs in allergic diseases: EAACI-GA2LEN consensus report. Allergy 62: 683–694
Burney P, Potts J, Makowska J, Kowalski M, Phillips J, Gnatiuc L, et al (2008) A case-control study of the relation between plasma selenium and asthma in European populations: a GA2LEN project. Allergy 63: 865–871
Shaheen S, Potts J, Gnatiuc L, Makowska J, Kowalski ML, Joos G, et al (2008) The relation between paracetamol use and asthma: a GA2LEN European case-control study. Eur Respir J 32: 1231–1236
Keil T, Kulig M, Simpson A, Custovic A, Wickman M, Kull I, et al (2006) European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs – a GA2LEN initiative. Allergy 61: 221–228
Keil T, Kulig M, Simpson A, Custovic A, Wickman M, Kull I, et al (2006) European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures-a GA2LEN initiative. Allergy 61: 1104–1111
Eller E, Roll S, Chen CM, Herbarth O, Wichmann HE, von Berg A, et al (2008) Meta-analysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA2LEN initiative. Allergy 63: 1491–1498
Almqvist C, Worm M, Leynaert B (2008) Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63: 47–57
Tricon S, Willers S, Smit H, Burney P, Devereux A, Frew A, et al (2006) Nutrition and allergic diseases. Clin Exp Rev 6: 117–188
Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, et al (2007) Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 62: 457–470
Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M (2008) In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205: 2887–2898
Brunekreef B (2008) Environmental epidemiology and risk assessment. Toxicol Lett 180: 118–122
Brunekreef B (2007) Health effects of air pollution observed in cohort studies in Europe. J Expo Sci Environ Epidemiol 17 [Suppl 2]: S61–65
Madsen C, Lodrup-Carlsen K, Hoek G, Oftedal B, Nasdaf P, Meliefste K, et al (2007) Modeling the intraurban variability of outdoor traffic pollution in Oslo, Norway – a GA2LEN study. Atmosph Environ 41: 7500–7511
Aguilera I, Sunyer J, Fernandez-Patier R, Hoek G, Aguirre-Alfaro A, Meliefste K, et al (2008) Estimation of outdoor NO(x), NO(2), and BTEX exposure in a cohort of pregnant women using land use regression modeling. Environ Sci Technol 42: 815–821
Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, et al (2007) Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 370: 336–341
Radon K, Gerhardinger U, Schulze A, Zock JP, Norback D, Toren K, et al (2008) Occupation and adult onset of rhinitis in the general population. Occup Environ Med 65: 38–43
Medina-Ramon M, Zock JP, Kogevinas M, Sunyer J, Basagana X, Schwartz J, et al (2006) Short-term respiratory effects of cleaning exposures in female domestic cleaners. Eur Respir J 27: 1196–1203
Radon K, Huemmer S, Dressel H, Windstetter D, Weinmayr G, Weiland S, et al (2006) Do respiratory symptoms predict job choices in teenagers? Eur Respir J 27: 774–778
Riu E, Dressel H, Windstetter D, Weinmayr G, Weiland S, Vogelberg C, et al (2007) First months of employment and new onset of rhinitis in adolescents. Eur Respir J 30: 549–555
Bousquet J, Anto JM, Bachert C, Bousquet PJ, Colombo P, Crameri R, et al (2006) Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 61: 671–680
Bousquet PJ, Chatzi L, Jarvis D, Burney P (2008) Assessing skin prick tests reliability in ECRHS-I. Allergy 63: 341–346
Bousquet PJ, Hooper R, Kogevinas M, Jarvis D, Burney P (2007) Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I. Clin Exp Allergy 37: 780–787
Bousquet PJ, Leynaert B, Neukirch F, Sunyer J, Janson CM, Anto J, et al (2008) Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy 63: 1301–1309
Watelet JB, Van Zele T, Gjomarkaj M, Canonica GW, Dahlen SE, Fokkens W, et al (2006) Tissue remodelling in upper airways: where is the link with lower airway remodelling? Allergy 61: 1249–1258
Gagliardo R, La-Grutta S, Chanez P, Profita M, Paterno A, Cibella F, et al (2009) Noninvasive markers of airway inflammation and remodeling in childhood asthma. Pediatr Allergy Immunol (in press)
Lang A, Carlsen KH, Haaland G, Devulapalli CS, Munthe-Kaas M, Mowinckel P, et al (2008) Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy 63: 1054–1060
Carlsen KH, Kowalski ML (2008) Asthma, allergy, the athlete and the Olympics. Allergy 63: 383–386
Baiardini I, Braido F, Brandi S, Tarantini F, Bonini S, Bousquet PJ, et al (2008) The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA2LEN review. Allergy 63: 1015–1030
Baiardini I, Braido F, Tarantini F, Porcu A, Bonini S, Bousquet PJ, et al (2008) ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 63: 660–669
Bousquet J, Bachert C, Canonica GW, Mullol J, van Cauwenberge P, Bindslev-Jensen C, et al (2009) Efficacy of desloratadine in intermittent allergic rhinitis. A Ga2len study. Allergy 64: 1516–1523
Bousquet J, Del-Carpio J, group A–S (2008) Improvement in disease-specific quality of life and reduced symptom burden measured with a visual analogue scale in subjects with persistent allergic rhinitis treated with desloratadine. American College of Allergy, Asthma and Immunology, Seattle, November 2008
Kabesch M (2006) Gene by environment interactions and the development of asthma and allergy. Toxicol Lett 162: 43–48
Kauffmann F, Cambon-Thomsen A (2008) Tracing biological collections: between books and clinical trials. JAMA 299: 2316–2318
Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, et al (2006) ARIA update: I – Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 117: 1054–1062
Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH, et al (2006) Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy 61: 681–692
Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, et al (2007) Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN. Allergy 62 [Suppl 84]: S1–41
Bousquet J, Bindslev-Jensen C, Canonica GW, Fokkens W, Kim H, Kowalski M, et al (2004) The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy 59 [Suppl 77]: S4–16
Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, et al (2006) Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 61: 1086–1096
Custovic A, Wijk RG (2005) The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA2LEN). Allergy 60: 1112–1115
Passalacqua G, Durham SR (2007) Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119: 881–891
van Weel C (2008) General practitioners' central role in management of asthma and allergic rhinitis. Allergy 63: 1005–1007
Ryan D, van Weel C, Bousquet J, Toskala E, Ahlstedt S, Palkonen S, et al (2008) Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 63: 981–989
Bousquet J, Reid J, van Weel C, Baena Cagnani C, Canonica GW, Demoly P, et al (2008) Allergic rhinitis management pocket reference 2008. Allergy 63: 990–996
Zuberbier T, Worm M (2006) Allergies and the skin, an interdisciplinary approach in GA2LEN and EAACI activities. Allergy 61: 1373–1376
Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al (2006) EAACI/GA2LEN/EDF guideline: management of urticaria. Allergy 61: 321–331
Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, et al (2006) EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 61: 316–320
Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, et al (2008) Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 63: 38–46
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wöhrl, S., Radon, K., Ring, J. et al. GA2LEN (Global Allergy and Asthma European Network), die Perspektive der deutschsprachigen Zentren. Wien Klin Wochenschr 121, 589–597 (2009). https://doi.org/10.1007/s00508-009-1246-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00508-009-1246-z